Showing 2,541 - 2,560 results of 18,354 for search 'significantly ((((greater decrease) OR (((we decrease) OR (a decrease))))) OR (linear decrease))', query time: 0.57s Refine Results
  1. 2541

    The sequences of si-RNAs used in this study. by Changji Li (4806930)

    Published 2024
    “…Using a mouse xenograft model, we demonstrated that the inhibition of CRNN led to a decline in cSCC tumor growth in a living organism, providing evidence of CRNN’s involvement in cSCC occurrence and development. …”
  2. 2542

    Primary antibodies used for immunoblot analysis. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    “…IRE1 silencing led to activation of TP53 and CDKN1A/p21 in conjunction with increased DNA damage and chromosome instability, while decreasing heterochromatin as well as DNA and histone H3K9me3 methylation. …”
  3. 2543

    The hourly temperatures in the phytotron. by Lifeng Guo (17320116)

    Published 2025
    “…After 10 days of exposure to LTS, the pollen viability decreased most significantly at the heading stage by 44.67%, followed by the booting and the tillering stages. …”
  4. 2544

    Fuchioka dataset 251021. by Yusuke Fuchioka (22806178)

    Published 2025
    “…Recent advances in 3D-MRI analysis have enabled quantitative cartilage thickness measurement. We hypothesized that OWHTO would result in measurable decreases in the PF joint cartilage thickness, predominantly medially and detectable using quantitative 3D-MRI. …”
  5. 2545

    (a to g) Administration of vitamin D3 increased serum phosphorus and triglycerides. by Vidya G. Bettada (22208808)

    Published 2025
    “…Analyses of serum cholesterol, HDL and triglycerides also showed a non-significant decrease in the serum HDL level upon treatment with 125 µg/Kg vitamin D3, but a noticeable increase in the serum triglyceride level was observed with 125 µg/Kg of vitamin D3.…”
  6. 2546

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  7. 2547

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  8. 2548

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  9. 2549

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  10. 2550

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  11. 2551

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  12. 2552

    Development and Use of a Galectin-1-Specific Nanobody for Tumor Imaging and Elucidating the Role of Galectin‑1 in Cancer by Philippine Granger Joly de Boissel (21688159)

    Published 2025
    “…Galectin-1 (GAL-1) plays a crucial role in cancer biology, especially in triple-negative breast cancer (TNBC), where it facilitates immune evasion and tumor progression. …”
  13. 2553

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  14. 2554

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  15. 2555

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  16. 2556

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  17. 2557
  18. 2558

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  19. 2559

    Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

    Published 2025
    “…Additionally, the effect of pressure variations (from 8 to 4 MPa at 288.2 K) was analyzed, revealing that a lower pressure decreases both the gas uptake and formation kinetics due to a reduced driving force. …”
  20. 2560